UY27843A1 - Composicion de vacuna - Google Patents
Composicion de vacunaInfo
- Publication number
- UY27843A1 UY27843A1 UY27843A UY27843A UY27843A1 UY 27843 A1 UY27843 A1 UY 27843A1 UY 27843 A UY27843 A UY 27843A UY 27843 A UY27843 A UY 27843A UY 27843 A1 UY27843 A1 UY 27843A1
- Authority
- UY
- Uruguay
- Prior art keywords
- meningococcal
- ampoule
- prevalent
- country
- bactericidal activity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a composiciones de vacuna para la prevención o el tratamiento eficaz de enfermedad por Neisseria, preferiblemente meningocócica. Las vacunas de la invención comprende n una composición meningocócica multivalente de ampolla que comprende al menos una ampolla con actividad bactericida homóloga que deriva de una cepa meningocócica con un sobserotipo que es prevalente en un país de uso, y al menos una ampolla con actividad bactericida heteróloga que deriva de una cepa meningocócica que no necesita tener un subserotipo que sea prevalente en el país de uso.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0213622.4A GB0213622D0 (en) | 2002-06-13 | 2002-06-13 | Vaccine Corporation |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27843A1 true UY27843A1 (es) | 2003-12-31 |
Family
ID=9938532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27843A UY27843A1 (es) | 2002-06-13 | 2003-06-11 | Composicion de vacuna |
Country Status (20)
Country | Link |
---|---|
US (1) | US20060110412A1 (es) |
EP (1) | EP1565211A2 (es) |
JP (1) | JP2005531614A (es) |
KR (1) | KR20050049431A (es) |
CN (1) | CN100387298C (es) |
AR (1) | AR040204A1 (es) |
AU (1) | AU2003236734A1 (es) |
BR (1) | BR0311777A (es) |
CA (1) | CA2488782A1 (es) |
CL (1) | CL2003001192A1 (es) |
CU (1) | CU23552A1 (es) |
GB (1) | GB0213622D0 (es) |
MX (1) | MXPA04012568A (es) |
NO (1) | NO20050132L (es) |
NZ (1) | NZ560766A (es) |
PE (1) | PE20040562A1 (es) |
RU (1) | RU2005100509A (es) |
UY (1) | UY27843A1 (es) |
WO (1) | WO2003105890A2 (es) |
ZA (1) | ZA200409547B (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001280883A1 (en) | 2000-07-27 | 2002-02-13 | The Children's Hospital & Research Center At Oakland | Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
GB2414667A (en) * | 2004-06-03 | 2005-12-07 | Isis Innovation | Vaccine compositions of N. meningitidis PorA and FetA antigens |
GB0419627D0 (en) * | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
CA2590974C (en) | 2005-01-27 | 2017-10-03 | Children's Hospital & Research Center At Oakland | Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
DK2384765T3 (en) * | 2005-12-22 | 2017-01-09 | Glaxosmithkline Biologicals Sa | Vaccine against Streptococcus pneumoniae. |
BRPI0716518B8 (pt) | 2006-09-07 | 2021-05-25 | Glaxosmithkline Biologicals Sa | vacina de ipv e uso da mesma |
CA2702871A1 (en) | 2007-10-19 | 2009-04-23 | Novartis Ag | Meningococcal vaccine formulations |
WO2009062132A2 (en) | 2007-11-09 | 2009-05-14 | California Institute Of Technology | Immunomodulating compounds and related compositions and methods |
CN105044337A (zh) * | 2008-02-01 | 2015-11-11 | 圣诺菲·帕斯图尔有限公司 | 用于诊断肺炎链球菌的试验 |
MX2010009738A (es) | 2008-03-03 | 2010-09-30 | Irm Llc | Compuestos y composiciones como moduladores de la actividad de tlr. |
BRPI0923006A2 (pt) | 2008-12-17 | 2016-03-08 | Novartis Ag | vacinas meningococicas incluindo receptor de hemoglobina |
EP2440245B1 (en) | 2009-06-10 | 2017-12-06 | GlaxoSmithKline Biologicals SA | Benzonaphthyridine-containing vaccines |
CA2772103A1 (en) | 2009-08-27 | 2011-03-03 | Novartis Ag | Adjuvant comprising aluminium, oligonucleotide and polycation |
TWI445708B (zh) | 2009-09-02 | 2014-07-21 | Irm Llc | 作為tlr活性調節劑之化合物及組合物 |
ES2443952T3 (es) | 2009-09-02 | 2014-02-21 | Novartis Ag | Composiciones inmunógenas que incluyen moduladores de la actividad de TLR |
EP2486940B1 (en) * | 2009-10-08 | 2017-10-04 | Aeon Medix Inc. | Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof |
WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
ES2631977T3 (es) | 2009-12-15 | 2017-09-07 | Glaxosmithkline Biologicals Sa | Suspensión homogénea de compuestos inmunopotenciadores y usos de la misma |
US20130183350A1 (en) * | 2009-12-22 | 2013-07-18 | Kevin Harper | Immunogenic compositions |
EP2547357A1 (en) | 2010-03-18 | 2013-01-23 | Novartis AG | Adjuvanted vaccines for serogroup b meningococcus |
EA023725B1 (ru) | 2010-03-23 | 2016-07-29 | Новартис Аг | Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний |
US20110251156A1 (en) | 2010-04-07 | 2011-10-13 | Yue Shen | Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems |
BR112013005626B1 (pt) | 2010-09-10 | 2022-07-26 | Glaxosmithkline Biologicals Sa | Meningococo, processo para a preparação de uma cepa meningocócica, vesículas de membrana externa, composição farmacêutica imunogênica, e, uso de uma composição |
WO2012153302A1 (en) | 2011-05-12 | 2012-11-15 | Novartis Ag | Antipyretics to enhance tolerability of vesicle-based vaccines |
JP6273200B2 (ja) | 2011-07-12 | 2018-01-31 | ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド | 脂質含有psa組成物、その単離の方法および使用の方法 |
EP3299467B1 (en) | 2012-02-02 | 2021-08-11 | GlaxoSmithKline Biologicals SA | Promoters for increased protein expression in meningococcus |
ES2750366T3 (es) | 2012-03-08 | 2020-03-25 | Glaxosmithkline Biologicals Sa | Ensayo de potencia in vitro para vacunas meningocócicas basadas en proteína |
BR112014031386A2 (pt) | 2012-06-14 | 2017-08-01 | Pasteur Institut | vacinas para meningococos do sorogrupo x |
EP2892553A1 (en) | 2012-09-06 | 2015-07-15 | Novartis AG | Combination vaccines with serogroup b meningococcus and d/t/p |
US11331335B2 (en) | 2015-06-10 | 2022-05-17 | California Institute Of Technology | Sepsis treatment and related compositions methods and systems |
EP3337321A4 (en) | 2015-08-19 | 2019-07-17 | President and Fellows of Harvard College | LIPIDED PSA COMPOSITIONS AND METHOD |
EP3484441A4 (en) | 2016-07-15 | 2020-03-18 | President and Fellows of Harvard College | GLYCOLIPID COMPOSITIONS AND METHODS OF USE |
AU2017321039B2 (en) | 2016-09-02 | 2021-03-18 | Glaxosmithkline Biologicals Sa | Vaccines for Neisseria gonorrhoeae |
AU2021364838A1 (en) * | 2020-10-23 | 2023-06-08 | Omvax, Inc. | Compositions and methods for vaccination against neisseria gonorrhoeae |
GB202115077D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Assay |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9811475A (pt) * | 1997-07-17 | 2000-08-15 | North American Vaccine Inc | Conjugados imunogênicos compreendendo uma porina meningocóccica de grupo b e um polissacarìdeo de h. influenzae |
GB9918319D0 (en) * | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
AU2001280883A1 (en) * | 2000-07-27 | 2002-02-13 | The Children's Hospital & Research Center At Oakland | Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
-
2002
- 2002-06-13 GB GBGB0213622.4A patent/GB0213622D0/en not_active Ceased
-
2003
- 2003-06-10 BR BR0311777-4A patent/BR0311777A/pt not_active IP Right Cessation
- 2003-06-10 KR KR1020047019991A patent/KR20050049431A/ko not_active Application Discontinuation
- 2003-06-10 MX MXPA04012568A patent/MXPA04012568A/es not_active Application Discontinuation
- 2003-06-10 WO PCT/EP2003/006094 patent/WO2003105890A2/en active Application Filing
- 2003-06-10 CA CA002488782A patent/CA2488782A1/en not_active Abandoned
- 2003-06-10 NZ NZ560766A patent/NZ560766A/en not_active IP Right Cessation
- 2003-06-10 JP JP2004512791A patent/JP2005531614A/ja active Pending
- 2003-06-10 RU RU2005100509/13A patent/RU2005100509A/ru not_active Application Discontinuation
- 2003-06-10 CL CL200301192A patent/CL2003001192A1/es unknown
- 2003-06-10 CN CNB038162822A patent/CN100387298C/zh not_active Expired - Fee Related
- 2003-06-10 EP EP03735599A patent/EP1565211A2/en not_active Ceased
- 2003-06-10 AU AU2003236734A patent/AU2003236734A1/en not_active Abandoned
- 2003-06-10 US US10/529,064 patent/US20060110412A1/en not_active Abandoned
- 2003-06-11 PE PE2003000583A patent/PE20040562A1/es not_active Application Discontinuation
- 2003-06-11 AR ARP030102096A patent/AR040204A1/es not_active Application Discontinuation
- 2003-06-11 UY UY27843A patent/UY27843A1/es unknown
-
2004
- 2004-11-25 ZA ZA200409547A patent/ZA200409547B/en unknown
- 2004-12-10 CU CU20040285A patent/CU23552A1/es active IP Right Grant
-
2005
- 2005-01-11 NO NO20050132A patent/NO20050132L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2488782A1 (en) | 2003-12-24 |
WO2003105890A2 (en) | 2003-12-24 |
NZ560766A (en) | 2009-09-25 |
MXPA04012568A (es) | 2005-09-21 |
NO20050132L (no) | 2005-02-11 |
CU23552A1 (es) | 2010-07-20 |
RU2005100509A (ru) | 2006-06-10 |
CL2003001192A1 (es) | 2005-01-07 |
KR20050049431A (ko) | 2005-05-25 |
EP1565211A2 (en) | 2005-08-24 |
AU2003236734A1 (en) | 2003-12-31 |
GB0213622D0 (en) | 2002-07-24 |
CN1668329A (zh) | 2005-09-14 |
NO20050132D0 (no) | 2005-01-11 |
JP2005531614A (ja) | 2005-10-20 |
CN100387298C (zh) | 2008-05-14 |
ZA200409547B (en) | 2006-07-26 |
PE20040562A1 (es) | 2004-10-19 |
BR0311777A (pt) | 2005-03-29 |
US20060110412A1 (en) | 2006-05-25 |
WO2003105890A3 (en) | 2004-03-25 |
AR040204A1 (es) | 2005-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY27843A1 (es) | Composicion de vacuna | |
AR125327A2 (es) | Composiciones de neisseria meningitidis y métodos de las mismas | |
BRPI0510430A (pt) | composições e métodos para vacinação mucosal | |
CL2016000650A1 (es) | Composicion de vacuna que comprende un antigeno y una formulacion coadyuvante, que comprende al menos el 50 % v/v de una fase oleosa, monofosforil-lipido a (mpl-a) o un analogo del mismo y un oligonucleotido inmunoestimulate; y uso de la composición de vacuna para preparar un medicamento. | |
PT1187629E (pt) | Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador | |
PT1284998E (pt) | Eptideos imunogenicos sinteticos mas nao-amiloidogenicos homologos a beta-amiloides, destinados a induzir uma reaccao imunitaria contra os beta-amiloides e os depositos amiloides | |
CO5680456A2 (es) | Composiciones de vacunas que comprenden lipooligosacaridos del inmunotipo l2 y/o l3 a partir de lgtb-neisseria minigitidis | |
NO20082472L (no) | Vaksinesammensetninger omfattende en saponin adjuvant | |
CO5700790A2 (es) | Composiciones de vacuna que comprenden una interleucina 18 y sistema de adyuvante de saponina | |
BRPI0607017B8 (pt) | composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc | |
BR122017018225A8 (pt) | Composição fungicida, seus usos, agente fungicida, método para controlar fungos nocivos fitopatogênicos, e semente resistente a fungos nocivos fitopatogênicos | |
EA200702254A1 (ru) | Вакцинная композиция, содержащая в-субъединицу термолабильного токсина e.coli и антиген и адъювант | |
BRPI0414428A (pt) | composições farmacêuticas | |
CO6321162A2 (es) | Una vacuna que comprende una cantidad inmunogenica de un antigeno en somastatina y un adyuvante | |
AR109263A2 (es) | Composición que comprende moxidectina | |
CR9246A (es) | Formulaciones terapeuticas del factor de crecimiento de queratinocitos | |
ES2195169T3 (es) | Vacunas contra calmidias y composiciones inmunogenicas que contienen un antigeno de membrana externa y metodos para su preparacion. | |
AR077138A1 (es) | Composiciones farmaceuticas utiles para tratar el vhc | |
AR077125A1 (es) | Combinaciones farmaceuticas utiles para tratar el vhc | |
AR077139A1 (es) | Composiciones farmaceuticas utiles para tratar el vch | |
ATE547118T1 (de) | Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung | |
AR103427A1 (es) | Vacuna contra la fiebre aftosa | |
MY153290A (en) | Multivalent avian influenza vaccines | |
AR039664A1 (es) | Composicion farmaceutica que comprende un inhibidor de lipasa y glucomanan | |
AR048671A1 (es) | Procedimiento de vacunacion contra la infeccion testicular por bvdv |